CAREDX, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
CAREDX, INC. (CDNA) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period of 10.50 thousand shares for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-04-30.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod · last filed 2025-04-30
- CAREDX, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2025-03-31 was 10.50K shares, a 93.37% decline year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2024-12-31 was 241.91K shares, a 33.71% decline year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2024-09-30 was 155.93K shares, a 42.23% decline year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2024-06-30 was 88.85K shares, a 77.82% decline year-over-year.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2024 was 645.04K shares, a 42.75% decline from fiscal 2023.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2023 was 1.13M shares, a 59.43% increase from fiscal 2022.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2022 was 706.74K shares, a 144.81% increase from fiscal 2021.
- CAREDX, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2021 was 288.69K shares, a 16.72% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month |
|---|---|---|---|---|
| 2025-03-31 | 10.50K shares 10-Q · filed 2025-04-30 | 252.41K shares derived: sum of 2 quarters · filed 2025-04-30 | 408.35K shares derived: sum of 3 quarters · filed 2025-04-30 | 497.19K shares derived: sum of 4 quarters · filed 2025-04-30 |
| 2024-12-31 | 241.91K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 397.85K shares derived: sum of 2 quarters · filed 2025-02-28 | 486.69K shares derived: sum of 3 quarters · filed 2025-02-28 | 645.04K shares 10-K · filed 2025-02-28 |
| 2024-09-30 | 155.93K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | 244.78K shares derived: sum of 2 quarters · filed 2024-11-04 | 403.13K shares 10-Q · filed 2024-11-04 | 768.09K shares derived: sum of 4 quarters · filed 2024-11-04 |
| 2024-06-30 | 88.85K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | 247.19K shares 10-Q · filed 2024-07-31 | 612.15K shares derived: sum of 3 quarters · filed 2024-07-31 | 882.10K shares derived: sum of 4 quarters · filed 2024-07-31 |
| 2024-03-31 | 158.35K shares 10-Q · filed 2024-05-09 | 523.31K shares derived: sum of 2 quarters · filed 2024-05-09 | 793.25K shares derived: sum of 3 quarters · filed 2024-05-09 | 1.19M shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 364.96K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | 634.90K shares derived: sum of 2 quarters · filed 2024-02-28 | 1.04M shares derived: sum of 3 quarters · filed 2024-02-28 | 1.13M shares 10-K · filed 2024-02-28 |
| 2023-09-30 | 269.94K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | 670.48K shares derived: sum of 2 quarters · filed 2023-11-08 | 761.77K shares 10-Q · filed 2023-11-08 | 1.01M shares derived: sum of 4 quarters · filed 2023-11-08 |
| 2023-06-30 | 400.54K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 491.83K shares 10-Q · filed 2023-08-08 | 738.49K shares derived: sum of 3 quarters · filed 2023-08-08 | 927.45K shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 91.29K shares 10-Q · filed 2023-05-10 | 337.95K shares derived: sum of 2 quarters · filed 2023-05-10 | 526.91K shares derived: sum of 3 quarters · filed 2023-05-10 | 719.34K shares derived: sum of 4 quarters · filed 2023-05-10 |
| 2022-12-31 | 246.66K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | 435.62K shares derived: sum of 2 quarters · filed 2023-02-27 | 628.05K shares derived: sum of 3 quarters · filed 2023-02-27 | 706.74K shares 10-K · filed 2023-02-27 |
| 2022-09-30 | 188.96K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 381.39K shares derived: sum of 2 quarters · filed 2022-11-03 | 460.08K shares 10-Q · filed 2022-11-03 | 522.20K shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 192.43K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 271.12K shares 10-Q · filed 2022-08-04 | 333.24K shares derived: sum of 3 quarters · filed 2022-08-04 | 413.66K shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 78.69K shares 10-Q · filed 2022-05-05 | 140.81K shares derived: sum of 2 quarters · filed 2022-05-05 | 221.23K shares derived: sum of 3 quarters · filed 2022-05-05 | 297.43K shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 62.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 142.54K shares derived: sum of 2 quarters · filed 2022-02-24 | 218.74K shares derived: sum of 3 quarters · filed 2022-02-24 | 288.69K shares 10-K · filed 2022-02-24 |
| 2021-09-30 | 80.42K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | 156.62K shares derived: sum of 2 quarters · filed 2021-10-28 | 226.56K shares 10-Q · filed 2021-10-28 | 412.94K shares derived: sum of 4 quarters · filed 2021-10-28 |
| 2021-06-30 | 76.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | 146.15K shares 10-Q · filed 2021-07-29 | 332.53K shares derived: sum of 3 quarters · filed 2021-07-29 | 406.60K shares derived: sum of 4 quarters · filed 2021-07-29 |
| 2021-03-31 | 69.94K shares 10-Q · filed 2021-05-05 | 256.33K shares derived: sum of 2 quarters · filed 2021-05-05 | 330.40K shares derived: sum of 3 quarters · filed 2021-05-05 | 374.88K shares derived: sum of 4 quarters · filed 2021-05-05 |
| 2020-12-31 | 186.38K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | 260.46K shares derived: sum of 2 quarters · filed 2021-02-24 | 304.93K shares derived: sum of 3 quarters · filed 2021-02-24 | 346.66K shares 10-K · filed 2021-02-24 |
| 2020-09-30 | 74.08K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | 118.55K shares derived: sum of 2 quarters · filed 2020-10-29 | 160.28K shares 10-Q · filed 2020-10-29 | 202.30K shares derived: sum of 4 quarters · filed 2020-10-29 |
| 2020-06-30 | 44.48K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 86.20K shares 10-Q · filed 2020-08-04 | 128.22K shares derived: sum of 3 quarters · filed 2020-08-04 | 180.24K shares derived: sum of 4 quarters · filed 2020-08-04 |
| 2020-03-31 | 41.73K shares 10-Q · filed 2020-04-30 | 83.75K shares derived: sum of 2 quarters · filed 2020-04-30 | 135.77K shares derived: sum of 3 quarters · filed 2020-04-30 | 204.23K shares derived: sum of 4 quarters · filed 2020-04-30 |
| 2019-12-31 | 42.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | 94.04K shares derived: sum of 2 quarters · filed 2020-02-28 | 162.50K shares derived: sum of 3 quarters · filed 2020-02-28 | 187.23K shares 10-K · filed 2020-02-28 |
| 2019-09-30 | 52.02K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | 120.48K shares derived: sum of 2 quarters · filed 2019-10-31 | 145.21K shares 10-Q · filed 2019-10-31 | 175.55K shares derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-06-30 | 68.46K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | 93.19K shares 10-Q · filed 2019-08-01 | 123.53K shares derived: sum of 3 quarters · filed 2019-08-01 | 126.63K shares derived: sum of 4 quarters · filed 2019-08-01 |
| 2019-03-31 | 24.73K shares 10-Q · filed 2019-05-08 | 55.07K shares derived: sum of 2 quarters · filed 2019-05-08 | 58.17K shares derived: sum of 3 quarters · filed 2019-05-08 | 63.72K shares derived: sum of 4 quarters · filed 2019-05-08 |
| 2018-12-31 | 30.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | 33.44K shares derived: sum of 2 quarters · filed 2019-03-06 | 38.99K shares derived: sum of 3 quarters · filed 2019-03-06 | 46.49K shares 10-K · filed 2019-03-06 |
| 2018-09-30 | 3.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 8.65K shares derived: sum of 2 quarters · filed 2018-11-08 | 16.15K shares 10-Q · filed 2018-11-08 | 18.37K shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 5.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 13.05K shares 10-Q · filed 2018-08-09 | 15.27K shares derived: sum of 3 quarters · filed 2018-08-09 | 28.43K shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | 7.50K shares 10-Q · filed 2018-05-10 | 9.72K shares derived: sum of 2 quarters · filed 2018-05-10 | 22.88K shares derived: sum of 3 quarters · filed 2018-05-10 | 80.23K shares derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | 2.22K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | 15.38K shares derived: sum of 2 quarters · filed 2018-03-22 | 72.73K shares derived: sum of 3 quarters · filed 2018-03-22 | 80.89K shares 10-K · filed 2018-03-22 |
| 2017-09-30 | 13.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 70.51K shares derived: sum of 2 quarters · filed 2017-11-09 | 78.67K shares 10-Q · filed 2017-11-09 | |
| 2017-06-30 | 57.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | 65.51K shares 10-Q · filed 2017-08-11 | ||
| 2017-03-31 | 8.16K shares 10-Q · filed 2017-06-09 | |||
| 2016-12-31 | 61.30K shares 10-K · filed 2018-03-22 | |||
| 2015-12-31 | 8.20K shares 10-K · filed 2018-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |